Trials / Completed
CompletedNCT02587390
Effect of Gemcabene on the Pharmacokinetics of Simvastatin in Healthy Volunteers
A Study to Evaluate the Effects of Gemcabene on the Steady-State Pharmacokinetics and Pharmacodynamics of Simvastatin in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- NeuroBo Pharmaceuticals Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the effect of gemcabene on the pharmacokinetics of simvastatin 80 mg.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gemcabene 900 mg | 3x300 mg Gemcabene tablets orally once daily (QD) for 15 days |
| DRUG | Simvastatin 80 mg | 2x40 mg Simvastatin tablets orally once daily (QD) for 15 days |
Timeline
- Start date
- 2000-05-01
- Primary completion
- 2000-07-01
- Completion
- 2000-07-01
- First posted
- 2015-10-27
- Last updated
- 2020-04-09
Source: ClinicalTrials.gov record NCT02587390. Inclusion in this directory is not an endorsement.